Cost-Effectiveness of Extending Human Papillomavirus Vaccination to Population Subgroups Older Than 26 Years Who Are at Higher Risk for Human Papillomavirus Infection in the United States

Authors: Jean-François Laprise, Harrell W. Chesson, Lauri E. Markowitz, Mélanie Drolet, Marc Brisson

Published: 2024-11-25

DOI: 10.7326/m24-0421

Source: Full article

---

Abstract

No abstract found.